Lisa Foa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lisa Foa has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
- Robert Gasperini
School of Medicine, University of Tasmania, Hobart, Australia
19 shared publications - David Henry Small
Menzies Research Institute Tasmania University of Tasmania Hobart Tasmania Australia
10 shared publications - Kaylene M. Young
Menzies Institute for Medical Research University of Tasmania Hobart Australia
9 shared publications - Marta Bolós
Department of Molecular Neuropathology, Centro de Biología Molecular “Severo Ochoa” (UAM-CSIC), Madrid, Spain
5 shared publications - Amos C. Hung
Translational Research Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
4 shared publications - Camilla B. Mitchell
Department Clinical Pathology, MDHS, University of Melbourne, Melbourne, Australia
4 shared publications
Latest Publications
- Open Access
Disruption of the Homer1 coiled-coiled domain by a novel de novo human HOMER1 variant impairs protein scaffolding, calcium signalling, and synaptogenesis
Rare de novo variants in synaptic scaffolding proteins are increasingly recognized for their roles in driving abnormal neuronal connectivity underlying conditions such as epilepsy and autism spectrum disorder (ASD). Homer1b/c, a synaptic scaffolding protein, regulates a wide suite of synaptic functions including Ca 2+ signalling, dendritic spine morphogenesis and multiple forms of synaptic plasticity. Here we report a novel substitution mutation in the human HOMER1 gene, HOMER1 R297W , and demonstrate that Homer1b/c R297W expression dominant-negative like effect on Homer1-dependent functions. In dorsal root ganglion (DRG) sensory neurons, Homer1b/c1 R297W impairs axonal growth cone turning to gradients of brain-derived neurotrophic factor (BDNF), a process that requires functional store-operated Ca 2+ entry (SOCE). Accordingly, we found that SOCE was significantly blunted in both Homer1b/c R297W DRG growth cones and hippocampal neuron soma. In hippocampal neurons, Homer1b/c R297W lowered dendritic spine density and reduced endoplasmic reticulum infiltration into spines. Homer1b/c R297W hippocampal neurons also exhibited decreased synaptic metabotropic glutamate receptor 5 (mGluR5) expression and blunted dendritic Ca²⁺ increases following group-I mGluR activation. Super resolution imaging using direct stochastic optical reconstruction microscopy (dSTORM) further demonstrated that Homer1b/c R297W diminishes receptor clustering, uncoupling it from crucial binding partners including IP3R, mGluR5 and STIM1/2. Taken together, these findings highlight the importance of Homer1b/c’s tetrameric scaffolding in shaping axon guidance, dendritic spine dynamics and synaptic Ca²⁺ signalling. Disruption of these processes by Homer1b/c R297W offers valuable mechanistic insights into how rare de novo variants and altered protein scaffolding can contribute to the connectivity deficits implicated in neurodevelopmental and neurological disorders.
Open AccessDisruption of the Homer1 coiled-coiled domain by a novel de novo human HOMER1 variant impairs protein scaffolding, calcium signalling, and synaptogenesis
Rare de novo variants in synaptic scaffolding proteins are increasingly recognized for their roles in driving abnormal neuronal connectivity underlying conditions such as epilepsy and autism spectrum disorder (ASD). Homer1b/c, a synaptic scaffolding protein, regulates a wide suite of synaptic functions including Ca 2+ signalling, dendritic spine morphogenesis and multiple forms of synaptic plasticity. Here we report a novel substitution mutation in the human HOMER1 gene, HOMER1 R297W , and demonstrate that Homer1b/c R297W expression dominant-negative like effect on Homer1-dependent functions. In dorsal root ganglion (DRG) sensory neurons, Homer1b/c1 R297W impairs axonal growth cone turning to gradients of brain-derived neurotrophic factor (BDNF), a process that requires functional store-operated Ca 2+ entry (SOCE). Accordingly, we found that SOCE was significantly blunted in both Homer1b/c R297W DRG growth cones and hippocampal neuron soma. In hippocampal neurons, Homer1b/c R297W lowered dendritic spine density and reduced endoplasmic reticulum infiltration into spines. Homer1b/c R297W hippocampal neurons also exhibited decreased synaptic metabotropic glutamate receptor 5 (mGluR5) expression and blunted dendritic Ca²⁺ increases following group-I mGluR activation. Super resolution imaging using direct stochastic optical reconstruction microscopy (dSTORM) further demonstrated that Homer1b/c R297W diminishes receptor clustering, uncoupling it from crucial binding partners including IP3R, mGluR5 and STIM1/2. Taken together, these findings highlight the importance of Homer1b/c’s tetrameric scaffolding in shaping axon guidance, dendritic spine dynamics and synaptic Ca²⁺ signalling. Disruption of these processes by Homer1b/c R297W offers valuable mechanistic insights into how rare de novo variants and altered protein scaffolding can contribute to the connectivity deficits implicated in neurodevelopmental and neurological disorders.
- Open Access
- 27 August 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (36)
Selective optogenetic inhibition of Gα q or Gα i signaling by minimal RGS domains disrupts circuit functionality and circuit formation
Optogenetic techniques provide genetically targeted, spatially and temporally precise approaches to correlate cellular activities and physiological outcomes. In the nervous system, G protein-coupled receptors (GPCRs) have essential neuromodulatory functions through binding extracellular ligands to induce intracellular signaling cascades. In this work, we develop and validate an optogenetic tool that disrupts Gα q signaling through membrane recruitment of a minimal regulator of G protein signaling (RGS) domain. This approach, Photo-induced Gα Modulator—Inhibition of Gα q (PiGM-Iq), exhibited potent and selective inhibition of Gα q signaling. Using PiGM-Iq we alter the behavior of Caenorhabditis elegans and Drosophila with outcomes consistent with GPCR-Gα q disruption. PiGM-Iq changes axon guidance in cultured dorsal root ganglia neurons in response to serotonin. PiGM-Iq activation leads to developmental deficits in zebrafish embryos and larvae resulting in altered neuronal wiring and behavior. Furthermore, by altering the minimal RGS domain, we show that this approach is amenable to Gα i signaling. Our unique and robust optogenetic Gα inhibiting approaches complement existing neurobiological tools and can be used to investigate the functional effects neuromodulators that signal through GPCR and trimeric G proteins.
- 27 August 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (36)
Open AccessSelective optogenetic inhibition of Gα q or Gα i signaling by minimal RGS domains disrupts circuit functionality and circuit formation
Optogenetic techniques provide genetically targeted, spatially and temporally precise approaches to correlate cellular activities and physiological outcomes. In the nervous system, G protein-coupled receptors (GPCRs) have essential neuromodulatory functions through binding extracellular ligands to induce intracellular signaling cascades. In this work, we develop and validate an optogenetic tool that disrupts Gα q signaling through membrane recruitment of a minimal regulator of G protein signaling (RGS) domain. This approach, Photo-induced Gα Modulator—Inhibition of Gα q (PiGM-Iq), exhibited potent and selective inhibition of Gα q signaling. Using PiGM-Iq we alter the behavior of Caenorhabditis elegans and Drosophila with outcomes consistent with GPCR-Gα q disruption. PiGM-Iq changes axon guidance in cultured dorsal root ganglia neurons in response to serotonin. PiGM-Iq activation leads to developmental deficits in zebrafish embryos and larvae resulting in altered neuronal wiring and behavior. Furthermore, by altering the minimal RGS domain, we show that this approach is amenable to Gα i signaling. Our unique and robust optogenetic Gα inhibiting approaches complement existing neurobiological tools and can be used to investigate the functional effects neuromodulators that signal through GPCR and trimeric G proteins.
- 1 July 2021
- Published by Elsevier in Environmental Research
- Vol. 198, 110489
Adverse effects of prenatal exposure to residential dust on post-natal brain development
- 1 July 2021
- Published by Elsevier in Environmental Research
- Vol. 198, 110489
Adverse effects of prenatal exposure to residential dust on post-natal brain development
- 1 April 2021
- Published by Elsevier in Chemosphere
- Vol. 268, 129314
In utero exposure to diesel exhaust particles, but not silica, alters post-natal immune development and function
- 1 April 2021
- Published by Elsevier in Chemosphere
- Vol. 268, 129314
In utero exposure to diesel exhaust particles, but not silica, alters post-natal immune development and function
- Open Access
- 20 January 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (3) , 1016
Novel Short-Chain Quinones to Treat Vision Loss in a Rat Model of Diabetic Retinopathy
Diabetic retinopathy (DR), one of the leading causes of blindness, is mainly diagnosed based on the vascular pathology of the disease. Current treatment options largely focus on this aspect with mostly insufficient therapeutic long-term efficacy. Mounting evidence implicates mitochondrial dysfunction and oxidative stress in the central etiology of DR. Consequently, drug candidates that aim at normalizing mitochondrial function could be an attractive therapeutic approach. This study compared the mitoprotective compounds, idebenone and elamipretide, side-by-side against two novel short-chain quinones (SCQs) in a rat model of DR. The model effectively mimicked type 2 diabetes over 21 weeks. During this period, visual acuity was monitored by measuring optokinetic response (OKR). Vision loss occurred 5–8 weeks after the onset of hyperglycemia. After 10 weeks of hyperglycemia, visual function was reduced by 65%. From this point, the right eyes of the animals were topically treated once daily with the test compounds. The left, untreated eye served as an internal control. Only three weeks of topical treatment significantly restored vision from 35% to 58–80%, while visual acuity of the non-treated eyes continued to deteriorate. Interestingly, the two novel SCQs restored visual acuity better than idebenone or elamipretide. This was also reflected by protection of retinal pathology against oxidative damage, retinal ganglion cell loss, reactive gliosis, vascular leakage, and retinal thinning. Overall, mitoprotective and, in particular, SCQ-based compounds have the potential to be developed into effective and fast-acting drug candidates against DR.
- 20 January 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (3) , 1016
Open AccessNovel Short-Chain Quinones to Treat Vision Loss in a Rat Model of Diabetic Retinopathy
Diabetic retinopathy (DR), one of the leading causes of blindness, is mainly diagnosed based on the vascular pathology of the disease. Current treatment options largely focus on this aspect with mostly insufficient therapeutic long-term efficacy. Mounting evidence implicates mitochondrial dysfunction and oxidative stress in the central etiology of DR. Consequently, drug candidates that aim at normalizing mitochondrial function could be an attractive therapeutic approach. This study compared the mitoprotective compounds, idebenone and elamipretide, side-by-side against two novel short-chain quinones (SCQs) in a rat model of DR. The model effectively mimicked type 2 diabetes over 21 weeks. During this period, visual acuity was monitored by measuring optokinetic response (OKR). Vision loss occurred 5–8 weeks after the onset of hyperglycemia. After 10 weeks of hyperglycemia, visual function was reduced by 65%. From this point, the right eyes of the animals were topically treated once daily with the test compounds. The left, untreated eye served as an internal control. Only three weeks of topical treatment significantly restored vision from 35% to 58–80%, while visual acuity of the non-treated eyes continued to deteriorate. Interestingly, the two novel SCQs restored visual acuity better than idebenone or elamipretide. This was also reflected by protection of retinal pathology against oxidative damage, retinal ganglion cell loss, reactive gliosis, vascular leakage, and retinal thinning. Overall, mitoprotective and, in particular, SCQ-based compounds have the potential to be developed into effective and fast-acting drug candidates against DR.
- Open Access
Low-density lipoprotein receptor-related protein 1 (LRP1) is a negative regulator of oligodendrocyte progenitor cell differentiation in the adult mouse brain
Low-density lipoprotein receptor-related protein 1 (LRP1) is a large, endocytic cell surface receptor that is highly expressed by oligodendrocyte progenitor cells (OPCs), and LRP1 expression is rapidly downregulated as OPCs differentiate into oligodendrocytes (OLs). We report that the conditional deletion of Lrp1 from adult mouse OPCs ( Pdgfrα-CreER :: Lrp1 fl/fl ) increases the number of new myelinating OLs added to brain, but that each new cell elaborates a normal quantity of myelin. OPC proliferation is also elevated following Lrp1 deletion in vivo , however, this is likely to be a secondary, homeostatic response to increased OPC differentiation, as our in vitro experiments show that LRP1 is a direct negative regulator of OPC differentiation, not proliferation. Deleting Lrp1 from adult OPCs also enhances remyelination, as cuprizone-induced lesions are smaller in Lrp1 -deleted mice, and parenchymal OPCs produce a larger number of mature OLs. These data suggest that the selective blockade of LRP1 function on adult OPCs may enhance myelin repair in demyelinating diseases, such as multiple sclerosis.
Open AccessLow-density lipoprotein receptor-related protein 1 (LRP1) is a negative regulator of oligodendrocyte progenitor cell differentiation in the adult mouse brain
Low-density lipoprotein receptor-related protein 1 (LRP1) is a large, endocytic cell surface receptor that is highly expressed by oligodendrocyte progenitor cells (OPCs), and LRP1 expression is rapidly downregulated as OPCs differentiate into oligodendrocytes (OLs). We report that the conditional deletion of Lrp1 from adult mouse OPCs ( Pdgfrα-CreER :: Lrp1 fl/fl ) increases the number of new myelinating OLs added to brain, but that each new cell elaborates a normal quantity of myelin. OPC proliferation is also elevated following Lrp1 deletion in vivo , however, this is likely to be a secondary, homeostatic response to increased OPC differentiation, as our in vitro experiments show that LRP1 is a direct negative regulator of OPC differentiation, not proliferation. Deleting Lrp1 from adult OPCs also enhances remyelination, as cuprizone-induced lesions are smaller in Lrp1 -deleted mice, and parenchymal OPCs produce a larger number of mature OLs. These data suggest that the selective blockade of LRP1 function on adult OPCs may enhance myelin repair in demyelinating diseases, such as multiple sclerosis.
- 25 April 2019
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 39 (26) , 5095-5114
STIM1 Is Required for Remodeling of the Endoplasmic Reticulum and Microtubule Cytoskeleton in Steering Growth Cones
The spatial and temporal regulation of calcium signaling in neuronal growth cones is essential for axon guidance. In growth cones, the endoplasmic reticulum (ER) is a significant source of calcium signals. However, it is not clear whether the ER is remodeled during motile events to localize calcium signals in steering growth cones. The expression of the ER-calcium sensor, stromal interacting molecule 1 (STIM1) is necessary for growth cone steering toward the calcium-dependent guidance cue BDNF, with STIM1 functioning to sustain calcium signals through store-operated calcium entry. However, STIM1 is also required for growth cone steering away from semaphorin-3a, a guidance cue that does not activate ER-calcium release, suggesting multiple functions of STIM1 within growth cones (Mitchell et al., 2012). STIM1 also interacts with microtubule plus-end binding proteins EB1/EB3 (Grigoriev et al., 2008). Here, we show that STIM1 associates with EB1/EB3 in growth cones and that STIM1 expression is critical for microtubule recruitment and subsequent ER remodeling to the motile side of steering growth cones. Furthermore, we extend our data in vivo, demonstrating that zSTIM1 is required for axon guidance in actively navigating zebrafish motor neurons, regulating calcium signaling and filopodial formation. These data demonstrate that, in response to multiple guidance cues, STIM1 couples microtubule organization and ER-derived calcium signals, thereby providing a mechanism where STIM1-mediated ER remodeling, particularly in filopodia, regulates spatiotemporal calcium signals during axon guidance. SIGNIFICANCE STATEMENT Defects in both axon guidance and endoplasmic reticulum (ER) function are implicated in a range of developmental disorders. During neuronal circuit development, the spatial localization of calcium signals controls the growth cone cytoskeleton to direct motility. We demonstrate a novel role for stromal interacting molecule 1 (STIM1) in regulating microtubule and subsequent ER remodeling in navigating growth cones. We show that STIM1, an activator of store-operated calcium entry, regulates the dynamics of microtubule-binding proteins EB1/EB3, coupling ER to microtubules, within filopodia, thereby steering growth cones. The STIM1-microtubule-ER interaction provides a new model for spatial localization of calcium signals in navigating growth cones in the nascent nervous system.
- 25 April 2019
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 39 (26) , 5095-5114
STIM1 Is Required for Remodeling of the Endoplasmic Reticulum and Microtubule Cytoskeleton in Steering Growth Cones
The spatial and temporal regulation of calcium signaling in neuronal growth cones is essential for axon guidance. In growth cones, the endoplasmic reticulum (ER) is a significant source of calcium signals. However, it is not clear whether the ER is remodeled during motile events to localize calcium signals in steering growth cones. The expression of the ER-calcium sensor, stromal interacting molecule 1 (STIM1) is necessary for growth cone steering toward the calcium-dependent guidance cue BDNF, with STIM1 functioning to sustain calcium signals through store-operated calcium entry. However, STIM1 is also required for growth cone steering away from semaphorin-3a, a guidance cue that does not activate ER-calcium release, suggesting multiple functions of STIM1 within growth cones (Mitchell et al., 2012). STIM1 also interacts with microtubule plus-end binding proteins EB1/EB3 (Grigoriev et al., 2008). Here, we show that STIM1 associates with EB1/EB3 in growth cones and that STIM1 expression is critical for microtubule recruitment and subsequent ER remodeling to the motile side of steering growth cones. Furthermore, we extend our data in vivo, demonstrating that zSTIM1 is required for axon guidance in actively navigating zebrafish motor neurons, regulating calcium signaling and filopodial formation. These data demonstrate that, in response to multiple guidance cues, STIM1 couples microtubule organization and ER-derived calcium signals, thereby providing a mechanism where STIM1-mediated ER remodeling, particularly in filopodia, regulates spatiotemporal calcium signals during axon guidance. SIGNIFICANCE STATEMENT Defects in both axon guidance and endoplasmic reticulum (ER) function are implicated in a range of developmental disorders. During neuronal circuit development, the spatial localization of calcium signals controls the growth cone cytoskeleton to direct motility. We demonstrate a novel role for stromal interacting molecule 1 (STIM1) in regulating microtubule and subsequent ER remodeling in navigating growth cones. We show that STIM1, an activator of store-operated calcium entry, regulates the dynamics of microtubule-binding proteins EB1/EB3, coupling ER to microtubules, within filopodia, thereby steering growth cones. The STIM1-microtubule-ER interaction provides a new model for spatial localization of calcium signals in navigating growth cones in the nascent nervous system.
- Open Access
- 26 October 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 14158
A New Method for Targeted and Sustained Induction of Type 2 Diabetes in Rodents
Type 2 diabetes is a chronic metabolic disorder that is becoming a leading cause of morbidity and mortality. The prolonged time-course of human type 2 diabetes makes modelling of the disease difficult and additional animal models and methodologies are needed. The goal of this study was to develop and characterise a new method that allows controlled, targeted and sustained induction of discrete stages of type 2 diabetes in rodents. Using adult, male rats, we employed a three-week high fat-diet regimen and confirmed development of obesity-associated glucose intolerance, a key feature of human type 2 diabetes. Next, we utilised osmotic mini-pumps to infuse streptozotocin (STZ; doses ranging 80–200 mg/kg) over the course of 14-days to decrease insulin-producing capacity thus promoting hyperglycemia. Using this new approach, we demonstrate a dose-dependent effect of STZ on circulating glucose and insulin levels as well as glucose tolerance, while retaining a state of obesity. Importantly, we found that insulin secretion in response to a glucose load was present, but reduced in a dose-dependent manner by increasing STZ. In conclusion, we demonstrate a novel method that enables induction of discrete stages of type 2 diabetes in rodents that closely mirrors the different stages of type 2 diabetes in humans.
- 26 October 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 14158
Open AccessA New Method for Targeted and Sustained Induction of Type 2 Diabetes in Rodents
Type 2 diabetes is a chronic metabolic disorder that is becoming a leading cause of morbidity and mortality. The prolonged time-course of human type 2 diabetes makes modelling of the disease difficult and additional animal models and methodologies are needed. The goal of this study was to develop and characterise a new method that allows controlled, targeted and sustained induction of discrete stages of type 2 diabetes in rodents. Using adult, male rats, we employed a three-week high fat-diet regimen and confirmed development of obesity-associated glucose intolerance, a key feature of human type 2 diabetes. Next, we utilised osmotic mini-pumps to infuse streptozotocin (STZ; doses ranging 80–200 mg/kg) over the course of 14-days to decrease insulin-producing capacity thus promoting hyperglycemia. Using this new approach, we demonstrate a dose-dependent effect of STZ on circulating glucose and insulin levels as well as glucose tolerance, while retaining a state of obesity. Importantly, we found that insulin secretion in response to a glucose load was present, but reduced in a dose-dependent manner by increasing STZ. In conclusion, we demonstrate a novel method that enables induction of discrete stages of type 2 diabetes in rodents that closely mirrors the different stages of type 2 diabetes in humans.
- Open Access
- 1 October 2017
- Published by Elsevier in Molecular and Cellular Neuroscience
- Vol. 84, 29-35
How does calcium interact with the cytoskeleton to regulate growth cone motility during axon pathfinding?
- 1 October 2017
- Published by Elsevier in Molecular and Cellular Neuroscience
- Vol. 84, 29-35
Open AccessHow does calcium interact with the cytoskeleton to regulate growth cone motility during axon pathfinding?
- 1 October 2017
- Published by Elsevier in Molecular and Cellular Neuroscience
- Vol. 84, 1-3
Special issue on ‘Cytoskeleton-dependent regulation of neuronal network formation’
- 1 October 2017
- Published by Elsevier in Molecular and Cellular Neuroscience
- Vol. 84, 1-3
Special issue on ‘Cytoskeleton-dependent regulation of neuronal network formation’